Zimmer Biomet (ZBH) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Current Ratio
Quick Ratio
Cash & Equivalents
Total Assets
Total Liabilities
Shareholders Equity
Asset Composition
Debt Structure
Zimmer Biomet (ZBH) quarterly earnings & revenue
Zimmer Biomet (ZBH) reported revenue of $2.09B for Q1 2026, up 9.3% year-over-year, with net income of $238.10M and diluted EPS of $1.22.
Over the last four reported quarters, Zimmer Biomet generated $8.41B in revenue and $761.30M in net income.
Zimmer Biomet's next earnings report is scheduled for August 5, 2026 before market open; analysts estimate EPS of $2.01.
Zimmer Biomet quarterly results
| Fiscal quarter | Revenue | Revenue YoY | Net income | EPS (diluted) |
|---|---|---|---|---|
| Q1 2026 | $2.09B | +9.3% | $238.10M | $1.22 |
| Q4 2025 | $2.24B | +10.9% | $139.50M | $0.70 |
| Q3 2025 | $2.00B | +9.7% | $230.90M | $1.16 |
| Q2 2025 | $2.08B | +7.0% | $152.80M | $0.77 |
| Q1 2025 | $1.91B | +1.1% | $182.00M | $0.91 |
| Q4 2024 | $2.02B | +4.3% | $239.50M | $1.20 |
| Q3 2024 | $1.82B | +4.0% | $249.10M | $1.23 |
| Q2 2024 | $1.94B | +3.9% | $242.80M | $1.18 |
Zimmer Biomet (ZBH) — frequently asked questions
When does Zimmer Biomet (ZBH) report earnings next?
Zimmer Biomet is expected to report earnings on August 5, 2026 before market open. Analysts estimate EPS of $2.01.
What was ZBH's revenue last quarter?
Zimmer Biomet reported revenue of $2.09B in Q1 2026, up 9.3% from the same quarter a year earlier.
What was ZBH's EPS last quarter?
Zimmer Biomet reported diluted EPS of $1.22 in Q1 2026.
Is Zimmer Biomet profitable?
Zimmer Biomet is currently profitable, with $761.30M in net income over the last four reported quarters.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)